Cargando…

Evaluation of survival in patients after pancreatic head resection for ductal adenocarcinoma

BACKGROUND: Surgery remains the only curative option for the treatment of pancreatic adenocarcinoma (PDAC). The goal of this study was to investigate the clinical outcome and prognostic factors in patients after resection for ductal adenocarcinoma of the pancreatic head. METHODS: The data from 195 p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Distler, Marius, Rückert, Felix, Hunger, Maximilian, Kersting, Stephan, Pilarsky, Christian, Saeger, Hans-Detlev, Grützmann, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639824/ https://www.ncbi.nlm.nih.gov/pubmed/23607915 http://dx.doi.org/10.1186/1471-2482-13-12

Ejemplares similares

Chronic pancreatitis of the pancreatic remnant is an independent risk factor for pancreatic fistula after distal pancreatectomy
por: Distler, Marius, et al.
Publicado: (2014)

Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma
por: Rückert, F, et al.
Publicado: (2008)

The Role of Apoptosis in the Pathology of Pancreatic Cancer
por: Samm, Nicole, et al.
Publicado: (2010)

Simultaneous gene silencing of Bcl-2, XIAP and Survivin re-sensitizes pancreatic cancer cells towards apoptosis
por: Rückert, Felix, et al.
Publicado: (2010)

Curative resection of a primarily unresectable acinar cell carcinoma of the pancreas after chemotherapy
por: Distler, Marius, et al.
Publicado: (2009)

ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma
por: Grützmann, R, et al.
Publicado: (2004)

Neoadjuvant Therapy in Patients with Pancreatic Cancer: A Disappointing Therapeutic Approach?
por: Zimmermann, Carolin, et al.
Publicado: (2011)

Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis
por: Mayerle, Julia, et al.
Publicado: (2018)

The impact of surgical experience and frequency of practice on perioperative outcomes in pancreatic surgery
por: Krautz, Christian, et al.
Publicado: (2019)

Serum Tumor Markers in Pancreatic Cancer—Recent Discoveries
por: Rückert, Felix, et al.
Publicado: (2010)

Impact of Aspirin Intake on Postoperative Survival after Primary Pancreatic Resection of Pancreatic Ductal Adenocarcinoma—A Single-Center Evaluation
por: Hackner, Danilo, et al.
Publicado: (2023)

Proposal of a Standardized Questionnaire to Structure Clinical Peer Reviews of Mortality and Failure of Rescue in Pancreatic Surgery
por: Brunner, Maximilian, et al.
Publicado: (2021)

Examination of Apoptosis Signaling in Pancreatic Cancer by Computational Signal Transduction Analysis
por: Rückert, Felix, et al.
Publicado: (2010)

Pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head with venous resection
por: Flis, Vojko, et al.
Publicado: (2016)

Blood Glucose Homeostasis in the Course of Partial Pancreatectomy – Evidence for Surgically Reversible Diabetes Induced by Cholestasis
por: Ehehalt, Florian, et al.
Publicado: (2015)

Silenced ZNF154 Is Associated with Longer Survival in Resectable Pancreatic Cancer
por: Wiesmueller, Felix, et al.
Publicado: (2019)

Plasma Metabolome Profiling Identifies Metabolic Subtypes of Pancreatic Ductal Adenocarcinoma
por: Mahajan, Ujjwal Mukund, et al.
Publicado: (2021)

Upregulation of CD20 Positive B-Cells and B-Cell Aggregates in the Tumor Infiltration Zone is Associated with Better Survival of Patients with Pancreatic Ductal Adenocarcinoma
por: Brunner, Maximilian, et al.
Publicado: (2020)

Para-aortic lymph node metastases in pancreatic cancer should not be considered a watershed for curative resection
por: Hempel, Sebastian, et al.
Publicado: (2017)

Impact of Patient Age on Postoperative Short-Term and Long-Term Outcome after Pancreatic Resection of Pancreatic Ductal Adenocarcinoma
por: Hackner, Danilo, et al.
Publicado: (2022)

Metabolic biomarkers for the differential diagnosis of pancreatic ductal adenocarcinoma vs. chronic pancreatitis
por: Mayerle, Julia, et al.
Publicado: (2014)

Proteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma
por: Chen, Ru, et al.
Publicado: (2014)

Feedback within the Inter-Cellular Communication and Tumorigenesis in Carcinomas
por: Rückert, Felix, et al.
Publicado: (2012)

Plasma extracellular vesicle messenger RNA profiling identifies prognostic EV signature for non-invasive risk stratification for survival prediction of patients with pancreatic ductal adenocarcinoma
por: Han, Yi, et al.
Publicado: (2023)

Acid sphingomyelinase expression is associated with survival in resectable pancreatic ductal adenocarcinoma
por: Wilson, Gregory C., et al.
Publicado: (2023)

Precursor Lesions for Sporadic Pancreatic Cancer: PanIN, IPMN, and MCN
por: Distler, M., et al.
Publicado: (2014)

Can we predict long-term survival in resectable pancreatic ductal adenocarcinoma?
por: Gall, Tamara M.H., et al.
Publicado: (2019)

Cbl-b predicts postoperative survival in patients with resectable pancreatic ductal adenocarcinoma
por: Dong, Qian, et al.
Publicado: (2017)

Neoadjuvant and Adjuvant Treatments for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: The Current Status of Pancreatic Ductal Adenocarcinoma Treatment in Japan
por: Ei, Shigenori, et al.
Publicado: (2023)

Specific Subtypes of Carcinoma-Associated Fibroblasts Are Correlated with Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma
por: Knipper, Karl, et al.
Publicado: (2023)

Activation of Wnt signalling in stroma from pancreatic cancer identified by gene expression profiling
por: Pilarsky, Christian, et al.
Publicado: (2008)

Genetic Alterations Predict Long-Term Survival in Ductal Adenocarcinoma of the Pancreatic Head
por: Safi, Sami-Alexander, et al.
Publicado: (2022)

Google Goes Cancer: Improving Outcome Prediction for Cancer Patients by Network-Based Ranking of Marker Genes
por: Winter, Christof, et al.
Publicado: (2012)

Clinical significance of revised microscopic positive resection margin status in ductal adenocarcinoma of pancreatic head
por: You, Yunghun, et al.
Publicado: (2019)

Factors affecting long-term survival after surgical resection of pancreatic ductal adenocarcinoma
por: Yoon, Kyoung Won, et al.
Publicado: (2011)

The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma
por: Ruess, Dietrich A., et al.
Publicado: (2015)

Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival
por: Morales-Oyarvide, Vicente, et al.
Publicado: (2017)

The impact of SPARC expression on the survival of pancreatic ductal adenocarcinoma patients after curative resection
por: Murakawa, Masaaki, et al.
Publicado: (2019)

EGFR, but not COX-2, protein in resected pancreatic ductal adenocarcinoma is associated with poor survival
por: Fagman, Johan Bourghardt, et al.
Publicado: (2019)

The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resection
por: Gruber, Elisabeth S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_25bpv25pef5be1f5o0479bpq6g